Home > Articles posted by News Desk (Page 62)
FEATURE
on Jul 18, 2025
148 views 2 mins

BioRestorative Therapies, a leader in regenerative medicine, has reported highly encouraging results from its phase 2 clinical trial of BRTX-100, a stem cell-based treatment targeting chronic lumbar disc disease (cLDD). According to CEO Lance Alstodt, the trial demonstrated that over 74% of participants experienced more than a 50% improvement in function, with over 72% reporting […]

FEATURE
on Jul 18, 2025
164 views 2 mins

The price of gold experienced a slight decrease after achieving a three-week high on Monday, as investors turned their focus towards upcoming U.S. economic data and ongoing trade discussions between the U.S. and its partners. This movement in the gold market underscores the metal’s sensitivity to global economic indicators and geopolitical developments. Meanwhile, silver prices […]

FEATURE
on Jul 16, 2025
178 views 2 mins

Critical Metals Corp (Nasdaq: CRML) has announced the start of a 2000m resource diamond drilling program at the Tanbreez Rare Earth Project in Greenland, marking a significant step towards commercial production anticipated in 2026. This initiative is part of the company’s strategy to address the increasing demand for rare earth materials in the United States […]

FEATURE
on Jul 16, 2025
178 views 2 mins

Foremost Clean Energy Ltd. (NASDAQ: FMST) (CSE: FAT) has completed its acquisition of the Jean Lake Lithium-Gold Project in Manitoba’s Snow Lake District, securing full ownership through a final payment of $75,000 in cash and the issuance of $75,000 in common shares to Mount Morgan Resources Ltd. This transaction concludes a total purchase of $250,000 […]

FEATURE
on Jul 16, 2025
180 views 2 mins

ICR, a premier strategic communications and advisory firm, has announced the addition of Gabriel Hasson as its Global Head of Governance & Shareholder Advisory. This strategic hire highlights the increasing significance of governance, ESG (Environmental, Social, and Governance) strategies, and shareholder engagement in the corporate world. Hasson’s role will involve leading ICR’s efforts in advising […]

FEATURE
on Jul 16, 2025
205 views 2 mins

Pure Barre, the largest barre workout brand in the United States, is set to open its first Mountain View studio on July 17, introducing the community to its proprietary barre technique. The studio, located at 125B E El Camino Real, will be owned by Sophia and John Lin, a local husband and wife team who […]

FEATURE
on Jul 16, 2025
186 views 2 mins

ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) has been featured in a NetworkNewsWire editorial, shedding light on its innovative approach to mining. The editorial, titled ‘A New Mining Model Is Emerging — And Wall Street Is Paying Attention,’ emphasizes ESGold’s focus on redeveloping past-producing and legacy mine sites. This strategy leverages known volumes and existing infrastructure, […]

FEATURE
on Jul 16, 2025
164 views 2 mins

Lantern Pharma (NASDAQ: LTRN), a biotechnology firm at the forefront of using artificial intelligence to revolutionize oncology drug development, has announced a strategic partnership with IBN to spearhead its corporate communications efforts. This collaboration comes at a pivotal moment as Lantern Pharma advances its AI-guided pipeline, which includes promising therapies for a range of cancers […]

FEATURE
on Jul 16, 2025
157 views 3 mins

Fanny Miller, a renowned Latina media icon, and Esperanza Colin, a healthcare strategist, have jointly launched MedSynergy Communications. This new agency is set to revolutionize the health tourism industry by offering specialized services in marketing, bilingual public relations, and business formation for healthcare and wellness professionals. The initiative comes at a time when the demand […]

FEATURE
on Jul 16, 2025
165 views 3 mins

The U.S. Food and Drug Administration (FDA) has granted the Regenerative Medicine Advanced Therapy (RMAT) designation to GNSC-001, a pioneering gene therapy developed by Genascence Corporation for the treatment of knee osteoarthritis (OA). This designation underscores the therapy’s potential to address a significant unmet medical need by providing sustained inhibition of interleukin 1 (IL-1), a […]